Our public policy work covers multiple areas:
Further Alpha1 Antitrypsin Research and all of its possibilities.
Basic research of Alpha1 Antitrypsin and its pharmaceutical drug development with potential assistance from federal government funds is needed to complete the necessary research through U.S. taxpayers' contributions. Support is critical for moving our discoveries forward if we are going to reach the fastest level of awareness and timely treatments for those in need at any time! Cures are a dream we see in the future of diseases associated with Alpha1 Antitrypsin and its applications for better health.